Easton Pharmaceuticals Inc.

March 22, 2010 12:30 ET

Easton Pharmaceuticals Announces Completion of Name Change

TORONTO, ONTARIO--(Marketwire - March 22, 2010) - Easton Pharmaceuticals Inc. (PINK SHEETS:EAPH) (the "Company") announces it has completed its name change from LAM Industries to Easton Pharmaceuticals Inc, as previously released. Concurrent with its name change, the company's stock trading symbol and cusip # have also changed. Its new stock symbol is EAPH. The company's new cusip number is 277774 105.

John Easton, Chairman of Easton Pharmaceuticals stated, "We are excited to continue to execute on our corporate strategy starting with the change of the company's name". Mr. Easton further commented, "We are energized and focused on our corporate objectives of product commercialization, launch and expansion of our business throughout 2010 and beyond". 

About Easton Pharmaceuticals

Easton Pharmaceuticals maintains a portfolio of commercial and under development products utilizing the "VDM" technology. Easton Pharmaceuticals current strategic focus is the final commercialization and launch of its flagship product, Viorra, an over-the-counter aid for the treatment of FSAD (Female Sexual Arousal Disorder). Viorra is a topical, daily use product containing Generally Regarded as Safe substances as classified by the FDA. Easton Pharmaceuticals has created a comprehensive business and marketing strategy for Viorra, which the Company believes requires no further development and is currently ready for marketing and sale in a number of markets.

For more information please visit http://www.eastonpharmaceuticals.com

Contact Information